Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2006
10/19/2006WO2006108709A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors
10/19/2006WO2006108701A1 3- (1,2,4-triazol-3ylalkyl) azabriclo (3.1.0) hexane derivatives as modulators of dopamine d3 receptors
10/19/2006WO2006108699A1 Indazoles as glucocorticoid receptor ligands
10/19/2006WO2006108640A1 Phenylacetamides suitable as protein kinase inhibitors
10/19/2006WO2006108591A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/19/2006WO2006108487A1 (lh-ind0l-7-yl)-( (pyrimidin-2 -yl-amino) methanone derivatives and related compounds as igf-rl inhibitors for treating cancer
10/19/2006WO2006069395A3 Synthetic process for the preparation of biocyclic compounds
10/19/2006WO2006050964A3 Indinavir derivatives useful in immunoassay
10/19/2006WO2006050476A3 Pyrimidine derivatives as ion channel modulators and methods of use
10/19/2006WO2006014618A3 Substituted pyrazoles, compositions containing such compounds and methods of use
10/19/2006WO2005103041A3 Treatment of cns disorders using cns target modulators
10/19/2006WO2005014542A3 Novel n-substituted indolyl-3-glyoxylic acid amides, use thereof as a medicament against cancer, and method for the production thereof
10/19/2006US20060235223 Variolin derivatives and their use as antitumor agents
10/19/2006US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors
10/19/2006US20060235069 Benzamide modulators of metabotropic glutamate receptors
10/19/2006US20060235055 Therapeutic agents useful for treating pain
10/19/2006US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006US20060235024 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
10/19/2006US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006US20060235021 Phenylpyridazine derivatives as ligands for gaba receptors
10/19/2006US20060235019 Substituted quinazolinone compounds
10/19/2006US20060235017 e.g. 1-Methyl-7-(pyrimidin-4-yloxy)-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-amide; antiinflammatory, antidiabetic, analgesic agent; osteoarthritis, atherosclerosis, contact dermatitis, bone resorption diseases, reperfusion injury, asthma
10/19/2006US20060235015 Pyrrole-2,5-dione derivatives as liver x receptor modulators
10/19/2006US20060235014 Inhibitors of p38
10/19/2006US20060235004 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
10/19/2006US20060234984 Mitotic kinesin inhibitors
10/19/2006US20060230554 Cyanin-type compounds having an alkynyl linker arm
10/19/2006DE112004001502T5 Neurobeschützende und Anti-Proliferationsverbindungen Neurobeschützende and anti-proliferative compounds
10/19/2006DE102005061720B3 Preparing optically active omeprazole enantiomers, useful to treat stomach diseases, comprises oxidizing prochiral sulfide compound with oxidizing agent in presence of titanium complex catalyst and reacting the catalyst with chiral diols
10/19/2006DE102005016634A1 Neuartige Aza-Hetercyclen als Kinase-Inhibitoren Novel aza-heterocycles as kinase inhibitors
10/19/2006CA2604895A1 (1h-indol-7-yl)-( (pyrimidin-2-ylamino) methanone derivatives and related compounds as igf-r1 inhibitors for the treatment of cancer
10/19/2006CA2604836A1 Pyrimidine derivatives and their use in the treatment of cancer
10/19/2006CA2604773A1 Npy antagonists, preparation and use
10/19/2006CA2604516A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/19/2006CA2604042A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
10/19/2006CA2603941A1 Phenylacetamides suitable as protein kinase inhibitors
10/19/2006CA2603701A1 1,4-substituted piperazine derivative
10/19/2006CA2603320A1 Pyridylmethylsulfone derivative
10/19/2006CA2601986A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
10/19/2006CA2598207A1 Substituted chroman derivatives, method for the production and the use thereof in the form of antiphlogistics
10/18/2006EP1712550A2 Substituted triazole diamine derivatives as kinase inhibitors
10/18/2006EP1712548A2 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
10/18/2006EP1712242A1 Method of regulating phosphorylation of sr protein and antiviral agents comprising sr protein activity regulator as the active ingredient
10/18/2006EP1712232A1 Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/18/2006EP1711825A2 Conjugated small molecules
10/18/2006EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds
10/18/2006EP1711495A2 Quinoline, quinazoline, pyridine and pyrimidine counds and their use in the treatment of inflammation, angiogenesis and cancer
10/18/2006EP1711491A1 Heterocyclic derivatives as gpcr receptor agonists
10/18/2006EP1711485A1 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
10/18/2006EP1711484A1 Synthesis of cyanoimino-benzoimidazoles
10/18/2006EP1711474A1 5-phenypyridines and their use as microbicides
10/18/2006EP1711473A1 Substituted n-cyclohexylimidazolinones having an mch-modulatory effect
10/18/2006EP1711181A1 Quinoline derivatives and use thereof as mycobacterial inhibitors
10/18/2006EP1711179A2 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
10/18/2006EP1711175A1 Diurea derivatives
10/18/2006EP1572683B1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
10/18/2006EP1345932B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
10/18/2006EP1070713B1 Quinolonecarboxylic acid derivatives or salts thereof
10/18/2006EP0931063B1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
10/18/2006CN1849316A 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) Q uinolonecarboxylic acid derivative
10/18/2006CN1849315A Novel amides useful for treating pain
10/18/2006CN1849308A Thiophenylaminoimidazolines
10/18/2006CN1849307A Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
10/18/2006CN1849126A 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/18/2006CN1849122A Method of treating cancer using fpt inhibitors and at least two antineoplastic agents
10/18/2006CN1849121A Piperazine derivatives as bradyknin antagonist
10/18/2006CN1849120A 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/18/2006CN1847241A Synthesis process of 1-(6-chloro-3-pyridylmethyl)-N-nitroimidazolyl-2-imine
10/18/2006CN1847240A Prazole derivative and its salt and use
10/18/2006CN1847231A Process of preparing aromatic ring substituted ixooxazoline compound
10/18/2006CN1846697A New use of angiotensin ii antagonists
10/18/2006CN1280287C Process for producing crystal
10/18/2006CN1280277C Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring
10/18/2006CN1280276C 9-aminoacridine derivatives and process for the preparation thereof
10/18/2006CN1280275C Pyridione derivatives for tretment of atherosclerosis
10/18/2006CN1280271C Arylphenyl-substituted cyclic keto-enols
10/18/2006CN1280269C Aliphatic nitrogenous five-membered ring compounds
10/18/2006CN1280267C Sulfonylaminocarboxylic acids
10/18/2006CN1280259C Aryl aniline beta-2 adrenergic receptor agonists
10/17/2006US7122680 3-Substituted oxindole β3 agonsists
10/17/2006US7122677 NK1 antagonists
10/17/2006US7122675 Gamma secretase inhibitors
10/17/2006US7122674 Process for preparing high-purity hydroxyindolylglyoxylamides
10/17/2006US7122666 Antiinflammatory agents; autoimmune disease; antiarthritic agents
10/17/2006US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006US7122570 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
10/17/2006US7122562 Amine oxidase inhibitor; use in treatment of Alzheimer's disease and senile dementia
10/17/2006US7122560 Lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
10/17/2006US7122559 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/17/2006US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/17/2006US7122556 Phenylalanine enamide derivatives
10/17/2006US7122551 Metalloproteinase inhibitor compounds
10/17/2006US7122550 Protein kinase inhibitors
10/17/2006US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006US7122546 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders
10/17/2006US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/17/2006US7121707 Illuminated electrical cords and outlets
10/17/2006CA2339661C Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p